Kidney Cancer
Prostate Cancer
EAU Edu Platform on Bladder Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Upcoming event
ASCO Annual Meeting 2022
Home
/
Guidelines
Back
Tags
5-α reductase inhibitors
,
Androgen antagonists
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BCG
,
BCG therapy
,
BCG-unresponsive disease
,
Bladder neoplasms
,
Bladder-sparing therapy
,
Bladder-sparing trimodality
,
Chemoradiotherapy
,
Clinical pathways
,
Clinical staging
,
Collaborative care
,
Comorbidity
,
Cystectomy
,
Early recurrence patterns
,
EAU21
,
EMUC21
,
EORTC
,
ERBB2
,
ERCC2
,
ESMO21
,
ESOU21
,
ESOU22
,
Gene expression analysis
,
Guidelines
,
Hematuria
,
High-risk NMIBC
,
Highlight of the Month
,
Immune checkpoint
,
Immune checkpoint blockade
,
Immunoregulation
,
Immunotherapy
,
Intravesical therapy
,
Laparoscopic radical cystectomy
,
Masterclass
,
Masterclass on MIBC
,
Masterclass on NMIBC
,
Meta-analysis
,
Metastatic urothelial cancer
,
MIBC
,
Microscopic haematuria
,
Molecular subtypes
,
Multiparametric MRI
,
Neoadjuvant
,
Neoadjuvant chemotherapy
,
Neoplasm recurrence
,
Nephroureterectomy
,
NIBC
,
Non-visible haematuria
,
Nuclear matrix protein 22
,
Oncologic outcomes
,
Open radical cystectomy
,
Optical coherence
,
PD-L1
,
Pembrolizumab
,
PET
,
PLND
,
Postoperative complications
,
POUT trial
,
Prevention & control
,
Quality of life
,
Radical cystectomy
,
Radio-chemotherapy
,
Randomized controlled trial
,
RARC
,
RAZOR Trial
,
Recurrence
,
Robotic
,
Robotic prostatectomy
,
Robotic radical cystectomy
,
Robotic surgery
,
Surgical video
,
Surgical videos
,
Systematic review
,
Tomography
,
Transitional cell
,
Transitional cell carcinoma
,
Tregs
,
Urinary bladder neoplasms
,
Urinary diversion
,
Urological surgery
,
Urothelial cancer
,
Urothelium
,
UROwebinar
,
UTUC
,
Webinar
Show all
Non-muscle-invasive Bladder Cancer (TaT1 and CIS)
European Association of Urology
View
Muscle-invasive and Metastatic Bladder Cancer
European Association of Urology
View
Upper Urinary Tract Urothelial Carcinoma
European Association of Urology
View
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
I agree
Read More